Philip P. Ahern, Jeremiah J. Faith, Jeffrey I. Gordon  Immunity 

Slides:



Advertisements
Similar presentations
Maintaining Cell Identity through Global Control of Genomic Organization Gioacchino Natoli Immunity Volume 33, Issue 1, Pages (July 2010) DOI: /j.immuni
Advertisements

Volume 34, Issue 5, Pages (May 2011)
Predicting Vaccine Responsiveness
A Few Good Commensals: Gut Microbes Use IFN-γ to Fight Salmonella
Volume 6, Issue 4, Pages (April 2010)
Nicholas A. Bokulich, Martin J. Blaser  Cell Metabolism 
Sustained Interactions between T Cell Receptors and Antigens Promote the Differentiation of CD4+ Memory T Cells  Chulwoo Kim, Theodore Wilson, Kael F.
Gut Nod2 Calls the Bone Marrow for Monocyte Reinforcements
Gut Microbiota: A Natural Adjuvant for Vaccination
Independence Day for IgA
Message in a Biota: Gut Microbes Signal to the Circadian Clock
Volume 21, Issue 1, Pages (January 2017)
The Lymphopenic Mouse in Immunology: From Patron to Pariah
Volume 22, Issue 3, Pages (September 2015)
Volume 23, Issue 3, Pages (March 2016)
Chronic Infections Capture Little Attention of the Masses
Through the Scope Darkly: The Gut Mycobiome Comes into Focus
Juan Rivera, Lino Tessarollo  Immunity 
Inflammatory Bowel Disease as a Model for Translating the Microbiome
Volume 2, Issue 1, Pages (January 2016)
Volume 163, Issue 1, Pages (September 2015)
Gut Reactions: Eosinophils Add another String to Their Bow
Suzanne Komili, Natalie G. Farny, Frederick P. Roth, Pamela A. Silver 
Volume 8, Issue 3, Pages (September 2010)
Vincent B. McGinty, Antonio Rangel, William T. Newsome  Neuron 
Volume 29, Issue 2, Pages (August 2008)
Volume 40, Issue 4, Pages (April 2014)
Volume 42, Issue 3, Pages (March 2015)
Hedging Your Bets by Learning Reward Correlations in the Human Brain
Chronic Infections Capture Little Attention of the Masses
Common TLR5 Mutations Control Cancer Progression
The Virome in Host Health and Disease
Volume 2, Issue 1, Pages (January 2016)
Volume 10, Issue 11, Pages (March 2015)
Volume 10, Issue 4, Pages (October 2011)
Testosterone: More Than Having the Guts to Win the Tour de France
Volume 35, Issue 5, Pages (November 2011)
Ruth E. Ley, Daniel A. Peterson, Jeffrey I. Gordon  Cell 
Volume 43, Issue 3, Pages (September 2015)
Role of the Microbiota in Immunity and Inflammation
Volume 20, Issue 6, Pages (December 2016)
Alien Invasions and Gut “Island Biogeography”
Volume 23, Issue 4, Pages (October 2005)
Principles and Strategies for Developing Network Models in Cancer
Veggies and Intact Grains a Day Keep the Pathogens Away
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  Axel Kallies, Annie Xin, Gabrielle T.
Homeostasis and Inflammation in the Intestine
Viral Safeguard: The Enteric Virome Protects against Gut Inflammation
Volume 22, Issue 3, Pages e4 (September 2017)
A Prescription for Human Immunology
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
CD4+ Lymphoid Tissue-Inducer Cells Promote Innate Immunity in the Gut
Asthma Prevention: Right Bugs, Right Time?
The Human Gut Microbiome: From Association to Modulation
Myung H. Kim, Elizabeth J. Taparowsky, Chang H. Kim  Immunity 
Rational Design of Evolutionarily Stable Microbial Kill Switches
Inflaming the CD8+ T Cell Response
Volume 34, Issue 5, Pages (May 2011)
Andrew L. Goodman, Jeffrey I. Gordon  Cell Metabolism 
Volume 1, Issue 2, Pages (August 2007)
Route Connection: Mouth to Intestine in Colitis
Courtney R. Plumlee, Brian S. Sheridan, Basak B. Cicek, Leo Lefrançois 
Rational Design of Evolutionarily Stable Microbial Kill Switches
Volume 163, Issue 1, Pages (September 2015)
Demonstrating causality in host-microbe interactions.
by Peter J. Turnbaugh, Vanessa K. Ridaura, Jeremiah J
Volume 37, Issue 2, Pages (August 2012)
Volume 25, Issue 6, Pages e5 (June 2019)
Host and Microbes Date Exclusively
IL-9 by INFERence Immunity
Presentation transcript:

Mining the Human Gut Microbiota for Effector Strains that Shape the Immune System  Philip P. Ahern, Jeremiah J. Faith, Jeffrey I. Gordon  Immunity  Volume 40, Issue 6, Pages 815-823 (June 2014) DOI: 10.1016/j.immuni.2014.05.012 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 An Experimental Pipeline for Dissecting the Interactions of Effector Strains Present in Complex Microbial Communities with the Host Immune System (A) The first step involves transplanting intact uncultured fecal microbiota from human donors to test the capacity of their gut microbial communities to impact immune phenotypes in recipient germ-free mice. In the case shown, the effects of different donor microbiota on the percent representation of an immune cell type of interest within a population of immune cells recovered from recipient gnotobiotic mice is plotted. Note that in principle, the approach can be applied to any phenotype of interest. (B) A representative human donor microbiota, nominated from the initial screen, is used to prepare a clonally arrayed culture collection in a multiwell plate, and the genome of each cultured member is sequenced. Subsets of members of this community are generated: subsets are either rationally designed or cultured strains are randomly assigned to subsets. Subsets (defined consortia) are then administered to recipient gnotobiotic mice. (C) The order the subsets are introduced into different mice is randomized to minimize batch effects and biases, and the phenotype of interest is assayed. (D) Sorting the tested subsets by their size (i.e., the total number of strains in the subset) enables estimation of the phenotype’s saturation point, if there is one. In the situation depicted, one can begin to observe phenotype saturation with subset sizes of three, while higher variation is observed in community sizes smaller than this. Therefore, using mice that are mono- or bicolonized would be an effective strategy for identifying which strains modulate this phenotype. (E) In cases where few members contribute to the phenotypic variation, effector strains can be identified by sorting the subsets based on the presence or absence of each strain individually, with p values determined with a t test. In the example shown, strains A, C, and E have little effect on the phenotype being measured whether they are present or absent, whereas strains B and D are present in most cases where the phenotype is observed. (F) More complex interactions involving multiple effector strains can be more accurately inferred with model-based approaches that consider the combined influence of all community members on the phenotype. In the example shown, feature selection can be used to demonstrate that the phenotype is manifest in cases where strain B or D are present and absent in all cases where B and D are absent, thus identifying the strains B or D as key effector strains for this phenotype. In E and F, the central horizontal bars show the mean value and the error bars represent the SEM. Each point represents a hypothetical response measured in an individual recipient mouse. Immunity 2014 40, 815-823DOI: (10.1016/j.immuni.2014.05.012) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Outline of How Random Subsetting Can Identify Immunogenic Effector Strains in a Hypothetical Gut Community Composed of 25 Members The figure shows hypothetical results of the induction of an immune cell type being studied, in order to illustrate the process by which random subsetting of clonally arrayed collections of cultured bacteria can be used to identify effector strains. (A) If all or many members of a community are capable of eliciting a phenotype, then recipients of all subset sizes will manifest the response. Despite each subset having different composition, no information is gained as to which strains are responsible, because there is low variation in the response and it already saturates at subset sizes as low as five bacteria (see text for further discussion of saturation). (B) If the ability to modify a phenotype is rare or restricted to just a single community member, then the value of the approach becomes evident. In the graph, there is a bimodal distribution in the response. By comparing the membership of consortia that promote induction of a population of interest to those that completely lack such populations, one can obtain a catalog of all strains that are (1) always present when the response is observed and (2) always absent when the response is not manifest. In the example shown in (B), although many communities elicit induction of the immune cell population of interest, there is only one effector strain common to all subsets. Followup colonizations with reduced size subsets can be used to confirm that the approach has indeed identified the correct effector strain and whether additional membership explains the capacity of a strain to imprint the phenotype. Horizontal lines represent mean values; each point depicts the immune cell response in an individual recipient mouse. Immunity 2014 40, 815-823DOI: (10.1016/j.immuni.2014.05.012) Copyright © 2014 Elsevier Inc. Terms and Conditions